-
Oncosil hits pancreatic cancer therapy trial goals
18 Sep 2025 02:54 GMT
… , clinicians have delivered the treatment endoscopically.
In effect, the … The study enrolled locally advanced pancreatic cancer (LAPC) patients, with a … by the US Food and Drug Administration (FDA).
“The … depart the Perth-based drug developer, after seven years …
-
Ligufalimab Gains FDA Orphan Drug Status for Acute Myeloid Leukemia
17 Sep 2025 19:48 GMT
… release from Akesobio.
The orphan drug designation program was created by … growth.
Unlike other CD47-targeting drugs, ligufalimab is designed to avoid … another in pancreatic cancer.
Why New Therapies Are Needed in AML
Treatment options …
-
Antimetabolite Drugs Market Set for Rapid Growth: Innovative Therapies and Rising Global Demand Driving Surge 2025-2033
17 Sep 2025 13:26 GMT
… by ongoing clinical trials and drug development initiatives.
Buy Now … dominates the antimetabolite drugs market, owing to advanced treatment facilities, strong … use of existing antimetabolite for pancreatic cancer.
Japan:
July 2025: Japanese …
-
The Lustgarten Foundation Announces Landmark Year of Fueling Cutting-Edge Pancreatic Cancer Research
16 Sep 2025 00:38 GMT
… drug targets based on an understanding of the biology of pancreatic cancer … testing of novel drugs and combinations in pancreatic cancer.
20% supports personalized … earlier detection and better treatments, and transforming pancreatic cancer into a curable …
-
A Slow and Steady Approach to Pancreatic Cancer Therapy
15 Sep 2025 21:27 GMT
… with a new class of drugs designed not to shrink tumors … -line standard of care treatments for patients with pancreatic cancer do a poor … framework that has governed cancer drug development for the past 50 …
-
<![CDATA[Ligufalimab Earns FDA Orphan Drug Designation in AML]]>
16 Sep 2025 23:34 GMT
… pancreatic cancer.
REFERENCES:
1. Akeso’s Ligufalimab (CD47 mAb) Receives FDA Orphan Drug …
2. Designating an Orphan Product: Drugs and Biological Products. US FDA … Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at …
-
<![CDATA[Ligufalimab Nets FDA Orphan Drug Designation in AML]]>
16 Sep 2025 18:59 GMT
… orphan drug designation from the FDA for the treatment of … frontline therapy for the treatment of patients with pancreatic cancer (NCT06953999).
References
… Akeso’s ligufalimab (CD47 mAb) receives FDA orphan drug …
-
Jim Edgar Cause Of Death: Former Illinois Governor Dies At 79 From Pancreatic Cancer
15 Sep 2025 01:47 GMT
… away due to complications from treatment for pancreatic cancer, which he had publicly …
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
16 Sep 2025 12:30 GMT
… cancers such as glioblastoma and pancreatic cancer remain devastatingly lethal, while pediatric … the cancer and rare disease treatment space. About Oncotelic Therapeutics Inc … also licenses and codevelops select drug candidates through joint ventures. …
-
FDA Grants Orphan Drug Status to Akeso’s Ligufalimab for AML
16 Sep 2025 11:59 GMT
… Food and Drug Administration for the treatment of acute … squamous cell carcinoma and pancreatic cancer, where it is … blood cancer with limited treatment options, especially for … drug designation, Akeso advances its mission to develop innovative treatments …
About
© 1995-2025